Articles by tag: immunology

IMP761 — first LAG-3 agonist passes Phase I in autoimmune diseases

Analysis of IMP761 data from Immutep at EULAR 2026: a new class of drugs for treating rheumatoid arthritis without total immunosuppression. Safety, mechanism, and prospects. Read more.

New type of cellular 'immune bomb': ruptosis against cancer

Mechanism of ruptosis discovered: kamikaze cells explode, destroying tumors locally. Learn how this will change cancer immunotherapy and infection control.

Mechanism linking obesity to chronic inflammation: the role of NLRP3

Scientists have found a mechanism how obesity activates the NLRP3 inflammasome, causing inflammation. The discovery leads to new drugs against diabetes. Read in analytics.